ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1968

Adverse Childhood Experiences and Outcomes of Systemic Lupus Erythematosus

Laura Trupin1, Patricia P. Katz1, Cristina Lanata1, Edward H. Yelin1, Lindsey A. Criswell1, Charles G. Helmick2, Jinoos Yazdany1 and Maria Dall'Era1, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: health disparities, outcomes and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Healthcare Disparities in Rheumatology

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Adverse childhood experiences such as extreme deprivation, neglect, abuse, parental separation or incarceration, have been associated with adult health status, including onset of rheumatic diseases. It has been hypothesized that cumulative trauma may have long term effects on immune regulation, putting children at greater risk for autoimmune disease as adults. However, there has been no research on the association of adverse experiences in childhood with outcomes of rheumatic diseases. In this analysis, we examine the association of adverse experiences in childhood with disease activity and damage, depression, and quality of life among adults with systemic lupus erythematosus (SLE).

Methods:   Data were derived from the California Lupus Epidemiology Study (CLUES), a population based, multi-ethnic cohort of patients with SLE begun in 2015. Participants completed an extensive interview including validated self-report measures of SLE activity (Systemic Lupus Activity Questionnaire; SLAQ) and damage (Brief Index of Lupus Damage; BILD), quality of life (SF-36), depression (Patient Health Questionnaire; PHQ-8) and sociodemographic measures.  They also completed the Adverse Childhood Experiences (ACE) questionnaire, a validated  8-item scale included in the Behavioral Risk Factor Surveillance System, covering parental separation, mental illness or suicide, incarceration, dysfunction due to drugs or alcohol, and verbal, physical or sexual abuse prior to age 18. Each endorsed item is given one point, and the scores were categorized as 0, 1, 2-3, and ≥4. We compared SLE outcomes by ACE score categories using ANOVA.  

Results:    To date, 126 CLUES participants have completed the ACE questionnaire. Participants were mostly women (88%) and racially diverse (30% white, 23% Hispanic, 15% African American, 30% Asian American).  Mean age was 44±14; mean age at diagnosis 27±12. Among the individual ACE items, parental separation or divorce was most commonly reported (34%), but nearly all the items were endorsed by at least 10% of participants. Median ACE score was 1, and 20 (16%) had a score of 4 or higher. ACE scores ≥4 were more common in Hispanic (24%) and African American (37%) participants, and in participants with poverty level income (50%). Scores did not differ by age at study entry or diagnosis. Higher ACE scores were associated with greater SLE activity and damage, poorer quality of life, and higher levels of depressive symptoms (Table).  

Conclusion:   Adverse childhood experiences are reported frequently among individuals with SLE and appear to be associated with poor SLE outcomes. As the cohort expands, we will compare ACE scores in the cohort to the general population and examine the associations between childhood experiences and SLE outcomes in a multivariable context that takes into account sociodemographic differences.

ACE Score categories

Outcomes

0

(n=52)

1

(n=26)

2-3

(n=28)

≥4

(n=20)

p-value

SLE activity (SLAQ)

5.4 (5.3)

6.3 (5.4)

12.9 (7.5)

12.6 (8.8)

<0.001

SLE damage (BILD)

1.9 (2.1)

1.5 (1.6)

1.9 (2.3)

3.3 (3.1)

0.05

Quality of life (SF36 PCS)

45.6 (10.6)

44.8 (9.0)

38.8 (11.0)

27.4 (8.9)

<0.001

Depressive symptoms (PHQ-8)

4.4 (4.1)

4.1 (3.7)

8.5 (5.2)

8.3 (4.2)

<0.001

                                                                        Table values are mean (sd) of outcome measure.

 


Disclosure: L. Trupin, None; P. P. Katz, None; C. Lanata, None; E. H. Yelin, None; L. A. Criswell, None; C. G. Helmick, None; J. Yazdany, None; M. Dall'Era, None.

To cite this abstract in AMA style:

Trupin L, Katz PP, Lanata C, Yelin EH, Criswell LA, Helmick CG, Yazdany J, Dall'Era M. Adverse Childhood Experiences and Outcomes of Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/adverse-childhood-experiences-and-outcomes-of-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adverse-childhood-experiences-and-outcomes-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology